Paclitaxel Treatment Options in Canada

A collection of 344 research studies where Paclitaxel is the interventional treatment. These studies are located in the Canada . Paclitaxel is used for conditions such as Breast Cancer, Ovarian Cancer and Non-Small Cell Lung Cancer.

Home

Canada

All Treatments

Paclitaxel

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer

NCT00486668

Unknown

The primary purpose of this study is to determine whether breast cancer tumors respond (as measured by pathologic complete response: the absence of microscopic evidence of invasive tumor cells in the breast) to combined chemotherapy of AC(doxorubicin and cyclophosphamide) followed by paclitaxel plus trastuzumab or lapatinib or both given before surgery to patients with HER2-positive breast cancer. Trastuzumab will also be given to all patients after surgery. The study will also evaluate the toxi... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

06/03/2016

Locations: MBCCOP, Gulf Coast, Mobile, Alabama +109 locations

MBCCOP, Gulf Coast, Mobile, Alabama

Scripps Cancer Center-San Diego, La Jolla, California

University of California, Irvine Medical Center, Long Beach, California

Pacific Shores Medical Group, Long Beach, California

St. Joseph Hospital, Orange, California

Desert Regional Medical Center Comprehensive Cancer Center, Palm Springs, California

Stanford University Medical Center, Palo Alto, California

Sutter Medical Center, Sacramento, California

Kaiser Permanente-San Diego, San Diego, California

Santa Rosa Memorial Hospital, Santa Rosa, California

Kaiser Permanente-Vallejo, Vallejo, California

University of Colorado Cancer Center, Aurora, Colorado

Memorial Hospital, Colorado Springs, Colorado

Kaiser Permanente-Franklin, Denver, Colorado

CCOP-Colorado Cancer Research Prog. Inc.(Administrative Only), Denver, Colorado

Kaiser Permanente Rock Creek, Lafayette, Colorado

Hartford Hospital, Hartford, Connecticut

Eastern Connecticut Hematology & Oncology Associates, Norwich, Connecticut

Sibley Memorial Hospital, Washington, District of Columbia

MD Anderson Cancer Center, Orlando, Florida

Phoebe Putney Memorial Hospital, Albany, Georgia

MBCCOP, Medical College of Georgia Research Institute, Augusta, Georgia

University of Hawaii, Honolulu, Hawaii

Kaiser Permanente Hawaii - Moanalua Med Center, Honolulu, Hawaii

Kootenai Cancer Center, Coeur D'Alene, Idaho

Rush University Medical Center, Chicago, Illinois

Decatur Memorial Hospital, Decatur, Illinois

Cancer Institute at Alexian Brothers Hospital Network, Elk Grove, Illinois

Edward Hospital, Naperville, Illinois

Edward Cancer Center Plainfield, Plainfield, Illinois

CCOP, Central Illinois, Springfield, Illinois

CCOP, Carle Cancer Center, Urbana, Illinois

St. Vincent Hospital and Health Care Center, Indianapolis, Indiana

CCOP, Northern Indiana Cancer Research Consortium, South Bend, Indiana

CCOP, Des Moines, IA, Des Moines, Iowa

University of Iowa, Iowa City, Iowa

CCOP, Sioux Community Cancer consortium, Sioux City, Iowa

CCOP, Wichita KS, Wichita, Kansas

University of Kentucky Medical Center, Lexington, Kentucky

NortonHealtcare Inc., Louisville, Kentucky

CCOP, Ochsner Clinic Foundation, New Orleans, Louisiana

Greater Baltimore Medical Center, Baltimore, Maryland

Franklin Square Hospital Center, Baltimore, Maryland

Boston Medical Center, Boston, Massachusetts

CCOP, Michigan Cancer Research Consortium, Ann Arbor, Michigan

Henry Ford Health System, Detroit, Michigan

Henry Ford Hospital, Detroit, Michigan

CCOP, Grand Rapids Clnical Oncology Program, Grand Rapids, Michigan

CCOP, Kalamazoo, MI, Kalamazoo, Michigan

Michigan State University - Breslin Cancer Center, Lansing, Michigan

CCOP, William Beaumont Hospital, Royal Oak, Michigan

Providence Hospital - Southfield, Southfield, Michigan

Hennepin County Medical Center, Minneapolis, Minnesota

CCOP, Metro-Minnesota, Minneapolis, Minnesota

University of Missouri-Ellis Fischel, Columbia, Missouri

CCOP, Kansas City (Administrative Only), Kansas City, Missouri

CCOP, Ozark Health Ventures LLC, Springfield, Missouri

Saint Louis UniversityHealth Sciences Center, St. Louis, Missouri

CCOP, Heartland Cancer Research, St. Louis, Missouri

CCOP, Montana Cancer Consortium, Billings, Montana

CCOP, Missouri Valley Consortium, Omaha, Nebraska

Cancer Institute of New Jersey, New Brunswick, New Jersey

Newark Beth Israel Medical Center, Newark, New Jersey

New York Oncology Hematology PC-Albany, Albany, New York

Cancer Center at Glens Falls Hospital, Glens Falls, New York

CCOP, Hematology-Oncology Associates of CNY, Syracuse, New York

Alamance Regional Medical Center, Burlington, North Carolina

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

CCOP, Southeast Cancer Control Consortium, Charlotte, North Carolina

Alamance Regional Medical Center - Off site Clinic, Mebane, North Carolina

Wake Forest University School of Medicine, Winston-Salem, North Carolina

Akron City Hospital, Akron, Ohio

Aultman Hospital, Canton, Ohio

Case Western Reserve/University Hospitals-Ireland Cancer Cntr., Cleveland, Ohio

Ohio State University, Columbus, Ohio

CCOP, Columbus, OH, Columbus, Ohio

CCOP, Dayton, OH, Dayton, Ohio

CCOP, Oklahoma, Tulsa, Oklahoma

Lehigh Valley Hospital, Allentown, Pennsylvania

Geisinger Clinic, Danville, Pennsylvania

Hershey Medical Center, Hershey, Pennsylvania

Albert Einstein Healthcare Network, Philadelphia, Pennsylvania

Allegheny General Hospital/Allegheny-Singer Research Institute, Pittsburgh, Pennsylvania

NSABP Foundation, Inc., Pittsburgh, Pennsylvania

University of Pittsburgh, Pittsburgh, Pennsylvania

Western Pennsylvania Hospital, Pittsburgh, Pennsylvania

Mercy Hospital, Scranton, Pennsylvania

Reading Hospital & Medical Center, West Reading, Pennsylvania

CCOP, Main Line Health, Wynnewood, Pennsylvania

CCOP, Upstate Carolina, Spartanburg, South Carolina

Sanford Cancer Center, Souix Falls, South Dakota

Thompson Cancer Survival Center-Dowell Springs, Knoxville, Tennessee

Joe Arrington Cancer Research & Treatment Center, Lubbock, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

MBCCOP, Virginia Commonwealth University, Richmond, Virginia

Puget Sound Oncology Consortium, Seattle, Washington

CCOP, Virginia Mason, Seattle, Washington

CCOP, Northwest, Tacoma, Washington

West Virginia University Hospitals Inc., Morgantown, West Virginia

Camden-Clark Memorial Hospital, Parkersburg, West Virginia

Wheeling Hospital, Wheeling, West Virginia

CCOP, Marshfield Clinic, Marshfield, Wisconsin

Medical College of Wisconsin, Milwaukee, Wisconsin

Odette Cancer Centre, Toronto, Ontario

Royal Victoria Hospital, Montreal, Quebec

Jewish General Hospital, Montreal, Quebec

St. Mary's Hospital Center, Montreal, Quebec

University of Montreal Hospital Group, Montreal, Quebec

Centre Hospitalier Affilie Universitaire De Quebec, Hospital du St-Sacrement, Quebec City, Quebec

MBCCOP, San Juan, Puerto Rico, San Juan, Not set

Conditions: Invasive Breast Cancer

Learn More ›

Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer

NCT00686959

Completed

This study will compare the overall survival of participants with locally-advanced, Stage III Non-Small Cell Lung Cancer (NSCLC) with nonsquamous cell histology.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/20/2016

Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Birmingham, Alabama +132 locations

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Birmingham, Alabama

Conditions: Non Small Cell Lung Cancer

Learn More ›

A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer

NCT01239732

Completed

This open-label, non-comparative, multi-center study will assess the safety profile and efficacy of Avastin (bevacizumab) when added to carboplatin and paclitaxel therapy in participants with epithelial ovarian cancer, fallopian tube carcinoma or primary peritoneal carcinoma. Participants will receive 15 milligrams/kilogram (mg/kg) Avastin intravenously (IV) on Day 1 of every cycle for up to 36 cycles of 3 weeks each, carboplatin (area under the plasma concentration-time curve \[AUC\] 5-6 mg/ml/... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

05/03/2016

Locations: Not set, Buenos Aires, Not set +241 locations

Not set, Buenos Aires, Not set

Not set, Rosario, Not set

Not set, Tucuman, Not set

Not set, Graz, Not set

Not set, Innsbruck, Not set

Not set, Ried-innkreis, Not set

Not set, Salzburg, Not set

Not set, Steyr, Not set

Not set, Villach, Not set

Not set, Wien, Not set

Not set, Salvador, BA

Not set, Fortaleza, CE

Not set, Goiania, GO

Not set, Curitiba, PR

Not set, Rio de Janeiro, RJ

Not set, Porto Alegre, RS

Not set, Piracicaba, SP

Not set, Sao Paulo, SP

Not set, Sofia, Not set

Not set, Varna, Not set

Not set, Veliko Tarnovo, Not set

Not set, Calgary, Alberta

Not set, Ottawa, Ontario

Not set, Toronto, Ontario

Not set, Montreal, Quebec

Not set, Quebec, Not set

Not set, Aalborg, Not set

Not set, Roskilde, Not set

Not set, Vejle, Not set

Not set, Cairo, Not set

Not set, Tanta, Not set

Not set, Tallinn, Not set

Not set, Tartu, Not set

Not set, Amiens, Not set

Not set, Bordeaux, Not set

Not set, Brest, Not set

Not set, Caen, Not set

Not set, Clermont Ferrand, Not set

Not set, Grenoble, Not set

Not set, Lille, Not set

Not set, Lyon, Not set

Not set, Marseille, Not set

Not set, Mougins, Not set

Not set, Paris, Not set

Not set, Reims CEDEX, Not set

Not set, Strasbourg, Not set

Not set, Toulouse, Not set

Not set, Villejuif, Not set

Not set, Athens, Not set

Not set, Heraklion, Crete, Not set

Not set, Larissa, Not set

Not set, Patras, Not set

Not set, Thessaloniki, Not set

Not set, Hong Kong, Not set

Not set, Budapest, Not set

Not set, Debrecen, Not set

Not set, Pecs, Not set

Not set, Szeged, Not set

Not set, Bangalore, Not set

Not set, Hyderabad, Not set

Not set, Jaipur, Not set

Not set, Kochi, Not set

Not set, New Delhi, Not set

Not set, Pune, Not set

Not set, Dublin, Not set

Not set, Afula, Not set

Not set, Beer Sheva, Not set

Not set, Haifa, Not set

Not set, Holon, Not set

Not set, Jerusalem, Not set

Not set, Kfar Saba, Not set

Not set, Petach Tikva, Not set

Not set, Ramat Gan, Not set

Not set, Rehovot, Not set

Not set, Tel Aviv, Not set

Not set, Napoli, Campania

Not set, Bologna, Emilia-Romagna

Not set, Meldola, Emilia-Romagna

Not set, Roma, Lazio

Not set, Genova, Liguria

Not set, Brescia, Lombardia

Not set, Milano, Lombardia

Not set, Monza, Lombardia

Not set, Saronno, Lombardia

Not set, Novara, Piemonte

Not set, Torino, Piemonte

Not set, Palermo, Sicilia

Not set, Firenze, Toscana

Not set, Pisa, Toscana

Not set, Perugia, Umbria

Not set, Terni, Umbria

Not set, Shuwaikh, Not set

Not set, Daugavpils, Not set

Not set, Riga, Not set

Not set, Kaunas, Not set

Not set, Klaipeda, Not set

Not set, Vilnius, Not set

Not set, Bitola, Not set

Not set, Skopje, Not set

Not set, Distrito Federal, Not set

Not set, Oaxaca, Not set

Not set, Toluca, Not set

Not set, Alkmaar, Not set

Not set, Amsterdam, Not set

Not set, Apeldoorn, Not set

Not set, Blaricum, Not set

Not set, Breda, Not set

Not set, Capelle a/d IJssel, Not set

Not set, Den Haag, Not set

Not set, Deventer, Not set

Not set, Dordrecht, Not set

Not set, Eindhoven, Not set

Not set, Leidschendam, Not set

Not set, Rotterdam, Not set

Not set, Sittard-Geleen, Not set

Not set, Utrecht, Not set

Not set, Bydgoszcz, Not set

Not set, Warszawa, Not set

Not set, Porto, Not set

Not set, Bucuresti, Not set

Not set, Cluj Napoca, Not set

Not set, Iasi, Not set

Not set, Barnaul, Not set

Not set, Moscow, Not set

Not set, Obninsk, Kaluzhskaya Region, Not set

Not set, Saint-Petersburg, Not set

Not set, Stavropol, Not set

Not set, UFA, Not set

Not set, Dammam, Not set

Not set, Belgrade, Not set

Not set, Nis, Not set

Not set, Bratislava, Not set

Not set, Kosice, Not set

Not set, Ljubljana, Not set

Not set, Maribor, Not set

Not set, Durban, Not set

Not set, Johannesburg, Not set

Not set, Sandton, Not set

Not set, Elda, Alicante

Not set, Oviedo, Asturias

Not set, Llerena (Badajoz), Badajoz

Not set, Manresa, Barcelona

Not set, Cádiz, Cadiz

Not set, Jerez de La Frontera, Cadiz

Not set, San Sebastian de Los Reyes, Guipuzcoa

Not set, San Sebastian, Guipuzcoa

Not set, Palma De Mallorca, Islas Baleares

Not set, Palma de Mallorca, Islas Baleares

Not set, Santiago de Compostela, La Coruña

Not set, Las Palmas de Gran Canaria, Las Palmas

Not set, Leganes, Madrid

Not set, Reus, Tarragona

Not set, La Laguna, Tenerife

Not set, Santa Cruz de Tenerife, Tenerife

Not set, San Juan, Valencia

Not set, Barakaldo, Vizcaya

Not set, Bilbao, Vizcaya

Not set, Albacete, Not set

Not set, Alicante, Not set

Not set, Badajoz, Not set

Not set, Barcelona, Not set

Not set, Burgos, Not set

Not set, Caceres, Not set

Not set, Castellon, Not set

Not set, Ciudad Real, Not set

Not set, Cordoba, Not set

Not set, Girona, Not set

Not set, Granada, Not set

Not set, Guadalajara, Not set

Not set, Jaen, Not set

Not set, La Coruña, Not set

Not set, Lugo, Not set

Not set, Madrid, Not set

Not set, Malaga, Not set

Not set, Navarra, Not set

Not set, Salamanca, Not set

Not set, Segovia, Not set

Not set, Sevilla, Not set

Not set, Toledo, Not set

Not set, Valencia, Not set

Not set, Valladolid, Not set

Not set, Zaragoza, Not set

Not set, Eskilstuna, Not set

Not set, Falun, Not set

Not set, Karlstad, Not set

Not set, Umeå, Not set

Not set, Uppsala, Not set

Not set, Örebro, Not set

Not set, Aarau, Not set

Not set, Baden, Not set

Not set, Bellinzona, Not set

Not set, Bern, Not set

Not set, Genève 14, Not set

Not set, Zürich, Not set

Not set, Taipei City, Not set

Not set, Taoyuan Hsien, Not set

Not set, Ankara, Not set

Not set, Diyarbakir, Not set

Not set, Istanbul, Not set

Not set, Montevideo, Not set

Conditions: Ovarian Cancer

Learn More ›

Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)

NCT00900627

Completed

The main purpose of this study is to determine if AZD8931 can improve the efficacy of standard chemotherapy for the treatment of advanced breast cancer. This study will be conducted in 2 parts: the first part (phase I) will determine a dose of AZD8931 that can be safely administered with paclitaxel chemotherapy. The second part (phase II) will determine the efficacy and safety of AZD8931 in combination with paclitaxel chemotherapy in breast cancer.

Gender:

ALL

Ages:

Between 18 years and 150 years

Trial Updated:

01/15/2016

Locations: Research Site, Brussels (Jette), Not set +39 locations

Research Site, Brussels (Jette), Not set

Research Site, Leuven, Not set

Research Site, Namur, Not set

Research Site, Sint-Niklaas, Not set

Research Site, Sao Paulo, Not set

Research Site, São Paulo, Not set

Research Site, Sofia, Not set

Research Site, Stara Zagora, Not set

Research Site, Varna, Not set

Research Site, Vratza, Not set

Research Site, Halifax, Nova Scotia

Research Site, London, Ontario

Research Site, Ottawa, Ontario

Research Site, Brno, Not set

Research Site, Jicin, Not set

Research Site, Olomouc, Not set

Research Site, Praha 2, Not set

Research Site, Praha 4 - Krc, Not set

Research Site, Praha 4, Not set

Research Site, Znojmo, Not set

Research Site, Villejuif Cedex, Not set

Research Site, Budapest, Not set

Research Site, Debrecen, Not set

Research Site, Györ, Not set

Research Site, Szeged, Not set

Research Site, Lido di Camaiore, Not set

Research Site, Modena, Not set

Research Site, Treviglio, Not set

Research Site, Ciudad de Panama, Not set

Research Site, Lima, Not set

Research Site, Barcelona, Not set

Research Site, Madrid, Not set

Research Site, Valencia, Not set

Research Site, Uppsala, Not set

Research Site, Chur, Not set

Research Site, Glasgow, Not set

Research Site, Leicester, Not set

Research Site, London, Not set

Research Site, Nottingham, Not set

Research Site, Surrey, Not set

Conditions: Neoplasms, Breast Neoplasms, Breast Cancer

Learn More ›

Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer

NCT01256762

Completed

The purpose of this study is to evaluate the efficacy and safety of treatment with imetelstat + paclitaxel (with or without bevacizumab) versus paclitaxel (with or without bevacizumab) alone for patients with locally recurrent or metastatic breast cancer who have not received chemotherapy or have received one non-taxane based chemotherapy for metastatic breast cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

12/22/2015

Locations: Clearview Cancer Center, Huntsville, Alabama +54 locations

Clearview Cancer Center, Huntsville, Alabama

Alta Bates Summit Medical Center, Berkeley, California

Southbay Oncology Hematology Partners, Campbell, California

Cancer Care Associates, Fresno, California

Memorial Miller Hospital, Long Beach, California

St. Joseph Hospital, Orange, California

Desert Regional Comprehensive Cancer Center, Palm Springs, California

UC San Diego, San Diego, California

Redwood Regional Medical Group, Santa Rosa, California

Univ. Colorado at Denver, Aurora, Colorado

Connecticut Oncology & Hematology, Torrington, Connecticut

Medical Oncology Hematology, Waterbury, Connecticut

Florida Oncology Associates, Jacksonville, Florida

Hematology Oncology Associates, Port St. Lucie, Florida

H. Lee Moffitt Cancer Center, Tampa, Florida

Northeast Georgia Cancer Care, Athens, Georgia

Peachtree Hematology Oncology, Atlanta, Georgia

Emory University, Atlanta, Georgia

Northeast Georgia Medical Center, Gainesville, Georgia

Central Georgia Cancer Care, Macon, Georgia

Summit Cancer Care, Savannah, Georgia

Kootenai Medical Center, Post Falls, Idaho

Ingalls Memorial Hospital, Chicago, Illinois

Rush University, Chicago, Illinois

Mid Illinois Hematology & Oncology, Normal, Illinois

Cancer Treatment Centers of America, Zion, Illinois

Indiana University, Indianapolis, Indiana

Community Hospitals of Indiana, Indianapolis, Indiana

Horizon Oncology Center, Lafayette, Indiana

Cancer Center of Kansas, Wichita, Kansas

Montgomery Cancer Care, Mount Sterling, Kentucky

Michigan State University, East Lansing, Michigan

New Mexico Cancer Center, Albuquerque, New Mexico

Prohealth Associates, Lake Success, New York

Stony Brook University, Stony Brook, New York

Carolinas Hematology/Oncology, Charlotte, North Carolina

Moses Cone Medical System, Greensboro, North Carolina

Case Western Reserve Univ., Cleveland, Ohio

Mercy Physicians of Oklahoma, Oklahoma City, Oklahoma

Cancer Care Associates, Tulsa, Oklahoma

Kaiser Northwest, Portland, Oregon

Pinnacle Health, Harrisburg, Pennsylvania

Penn. State Univ., Hershey, Pennsylvania

The Jones Clinic, Germantown, Tennessee

The West Clinic, Memphis, Tennessee

Scott & White Healthcare, Temple, Texas

Northern Utah Associates, Ogden, Utah

Peninsula Cancer Institute, Newport News, Virginia

Medical Oncology Associates, Spokane, Washington

Northwest Medical Specialties, Tacoma, Washington

Grand River Regional Cancer Centre, Kitchener, Ontario

Stronach Regional Cancer Centre at Southlake, Newmarket, Ontario

The Ottawa Hospital Cancer Centre, Ottawa, Ontario

Sunnybrook Health Services Centre, Toronto, Ontario

McGill University, Montreal, Quebec

Conditions: Locally Recurrent or Metastatic Breast Cancer

Learn More ›

Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer

NCT00005087

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Colony-stimulating factors such as filgrastim may increase the number of immune cells found in bone marrow or peripheral blood and may help a person's immune system recover from the side effects of chemotherapy. Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase II trial to study the effectiveness of paclitaxel, cisplatin, and filgrastim combined w... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/14/2015

Locations: University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama +234 locations

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama

Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama

Huntsville Hospital System, Huntsville, Alabama

MBCCOP - Gulf Coast, Mobile, Alabama

Alabama Oncology, LLC, Montgomery, Alabama

DCH Cancer Treatment Center, Tuscaloosa, Alabama

Foundation for Cancer Research and Education, Phoenix, Arizona

Mount Diablo Medical Center, Concord, California

City of Hope Comprehensive Cancer Center, Duarte, California

Saint Agnes Cancer Center, Fresno, California

California Cancer Center, Fresno, California

Sutter Health West Cancer Research Group, Greenbrae, California

Loma Linda University Medical Center, Loma Linda, California

Veterans Affairs Medical Center - Long Beach, Long Beach, California

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California

CCOP - Bay Area Tumor Institute, Oakland, California

Huntington Cancer Center, Pasadena, California

Robert and Beverly Lewis Family Cancer Care Center, Pomona, California

Radiation Oncology Center - Sacramento, Sacramento, California

Radiation Medical Group, Inc., San Diego, California

UCSF Comprehensive Cancer Center, San Francisco, California

O'Connor Hospital, San Jose, California

CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California

David Grant Medical Center, Travis Air Force Base, California

Memorial Hospital Cancer Center, Colorado Springs, Colorado

University of Colorado Cancer Center, Denver, Colorado

Saint Mary's Hospital and Medical Center, Grand Junction, Colorado

Hospital of St. Raphael, New Haven, Connecticut

CCOP - Christiana Care Health Services, Wilmington, Delaware

University of Florida Health Science Center, Gainesville, Florida

Florida Radiation Oncology Group, Jacksonville, Florida

Health First Holmes Regional Medical Center, Melbourne, Florida

CCOP - Mount Sinai Medical Center, Miami Beach, Florida

Veterans Affairs Medical Center - Miami, Miami, Florida

Sylvester Cancer Center, University of Miami, Miami, Florida

Baptist Hospital of Miami, Miami, Florida

MD Anderson Cancer Center Orlando, Orlando, Florida

Bay Medical Center, Panama City, Florida

Gulf Coast Cancer Treatment Center, Panama City, Florida

Sarasota Radiation and Medical Oncology Center, Sarasota, Florida

Tallahassee Memorial Healthcare, Tallahassee, Florida

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Emory University Hospital - Atlanta, Atlanta, Georgia

CCOP - Atlanta Regional, Atlanta, Georgia

Medical Center/John B. Amos Community Cancer Center, Columbus, Georgia

Regional Radiation Oncology Center at Rome, Rome, Georgia

MBCCOP - Hawaii, Honolulu, Hawaii

Northwest Community Hospital, Arlington Heights, Illinois

Northwestern Memorial Hospital, Chicago, Illinois

CCOP - Central Illinois, Decatur, Illinois

Ingalls Memorial Hospital, Harvey, Illinois

Loyola University Medical Center, Maywood, Illinois

Lutheran General Cancer Care Center, Park Ridge, Illinois

Methodist Medical Center of Illinois, Peoria, Illinois

St. John's Medical Center, Anderson, Indiana

Bloomington Hospital, Bloomington, Indiana

Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana

Clarian Health Partners Inc., Indianapolis, Indiana

Regional Cancer Center, Indianapolis, Indiana

Ball Memorial Hospital, Muncie, Indiana

CCOP - Northern Indiana CR Consortium, South Bend, Indiana

Wendt Regional Cancer Center of Finley Hospital, Dubuque, Iowa

Central Baptist Hospital, Lexington, Kentucky

Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky

James Graham Brown Cancer Center, Louisville, Kentucky

Louisville Radiation Oncology, Louisville, Kentucky

Merle M. Mahr Cancer Center, Madisonville, Kentucky

Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana

Tulane University School of Medicine, New Orleans, Louisiana

MBCCOP - LSU Medical Center, New Orleans, Louisiana

CCOP - Ochsner, New Orleans, Louisiana

Maine Medical Center, Portland, Maine

Anne Arundel Oncology Center, Annapolis, Maryland

Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland

Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland

Harbor Hospital Center, Baltimore, Maryland

Sinai Hospital of Baltimore, Baltimore, Maryland

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Peninsula Regional Medical Center, Salisbury, Maryland

Dana-Farber Cancer Institute, Boston, Massachusetts

Cape Cod Hospital, Hyannis, Massachusetts

Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts

CCOP - Ann Arbor Regional, Ann Arbor, Michigan

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Henry Ford Hospital, Detroit, Michigan

Hurley Medical Center, Flint, Michigan

McLaren Regional Cancer Center, Flint, Michigan

CCOP - Kalamazoo, Kalamazoo, Michigan

Marquette General Hospital, Marquette, Michigan

MidMichigan Medical Center - Midland, Midland, Michigan

CCOP - Beaumont, Royal Oak, Michigan

William Beaumont Hospital, Royal Oak, Michigan

William Beaumont Hospital - Troy, Troy, Michigan

Mayo Clinic Cancer Center, Rochester, Minnesota

CCOP - Metro-Minnesota, Saint Louis Park, Minnesota

Ellis Fischel Cancer Center - Columbia, Columbia, Missouri

CCOP - Kansas City, Kansas City, Missouri

Mallinckrodt Institute of Radiology, Saint Louis, Missouri

St. Louis University Health Sciences Center, Saint Louis, Missouri

Cancer Research for the Ozarks, Springfield, Missouri

CCOP - Cancer Research for the Ozarks, Springfield, Missouri

CCOP - Montana Cancer Consortium, Billings, Montana

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska

Methodist Hospital Cancer Center - Omaha, Omaha, Nebraska

Nebraska Health System, Omaha, Nebraska

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada

Norris Cotton Cancer Center, Lebanon, New Hampshire

Elliot Regional Cancer Center, Manchester, New Hampshire

Veterans Affairs Medical Center - East Orange, East Orange, New Jersey

John F. Kennedy Medical Center, Edison, New Jersey

Trinitas Hospital - Jersey Street Campus, Elizabeth, New Jersey

Monmouth Medical Center, Long Branch, New Jersey

South Jersey Regional Cancer Center, Millville, New Jersey

Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital, Mount Holly, New Jersey

Cancer Institute of New Jersey, New Brunswick, New Jersey

Newark Beth Israel Medical Center, Newark, New Jersey

Atlantic City Medical Center, Pomona, New Jersey

Valley Hospital, Ridgewood, New Jersey

Community Medical Center, Toms River, New Jersey

St. Francis Medical Center, Trenton, New Jersey

Associated Radiologists, P.A., Warren, New Jersey

Radiation Oncology Associates of Albuquerque, Albuquerque, New Mexico

Cancer Center of Albany Medical Center, Albany, New York

State University of New York Health Science Center at Brooklyn, Brooklyn, New York

New York Methodist Hospital, Brooklyn, New York

Roswell Park Cancer Institute, Buffalo, New York

Finger Lakes Radiation Oncology Center, Clifton Springs, New York

CCOP - North Shore University Hospital, Manhasset, New York

Herbert Irving Comprehensive Cancer Center, New York, New York

Champlain Valley Physicians Hospital Medical Center, Plattsburgh, New York

Vassar Brothers Medical Center, Poughkeepsie, New York

James P. Wilmot Cancer Center, Rochester, New York

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York

Riverhill Radiation Oncology, Yonkers, New York

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina

Northeast Medical Center, Concord, North Carolina

East Carolina University School of Medicine, Greenville, North Carolina

CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina

Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina

Trinity Cancer Care Center, Minot, North Dakota

Akron General Medical Center, Akron, Ohio

Akron City Hospital, Akron, Ohio

Christ Hospital, Cincinnati, Ohio

Barrett Cancer Center, Cincinnati, Ohio

Ireland Cancer Center, Cleveland, Ohio

University Hospitals of Cleveland, Cleveland, Ohio

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio

CCOP - Columbus, Columbus, Ohio

Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio

CCOP - Dayton, Dayton, Ohio

CCOP - Toledo Community Hospital, Toledo, Ohio

St. Anthony Hospital, Oklahoma City, Oklahoma

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

St. John Health System, Tulsa, Oklahoma

CCOP - Oklahoma, Tulsa, Oklahoma

CCOP - Columbia River Program, Portland, Oregon

Lehigh Valley Hospital, Allentown, Pennsylvania

St. Luke's Hospital Cancer Center, Bethlehem, Pennsylvania

Geisinger Medical Center, Danville, Pennsylvania

Mercy Fitzgerald Hospital, Darby, Pennsylvania

Delaware County Memorial Hospital, Drexel Hill, Pennsylvania

Pocono Cancer Center, East Stroudsburg, Pennsylvania

Milton S. Hershey Medical Center, Hershey, Pennsylvania

University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania

Veterans Affairs Medical Center - Philadelphia, Philadelphia, Pennsylvania

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Albert Einstein Cancer Center, Philadelphia, Pennsylvania

University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania

Mercy Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Western Pennsylvania Hospital, Pittsburgh, Pennsylvania

Reading Hospital and Medical Center, Reading, Pennsylvania

Mercy Hospital Cancer Center - Scranton, Scranton, Pennsylvania

Wilkes Barre General Hospital, Wilkes-Barre, Pennsylvania

York Cancer Center, York, Pennsylvania

Roger Williams Medical Center/BUSM, Providence, Rhode Island

CCOP - Greenville, Greenville, South Carolina

CCOP - Upstate Carolina, Spartanburg, South Carolina

Rapid City Regional Hospital, Rapid City, South Dakota

Jackson-Madison County General Hospital, Jackson, Tennessee

University of Tennessee Cancer Institute, Memphis, Tennessee

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee

Harrington Cancer Center, Amarillo, Texas

University of Texas Medical Branch, Galveston, Texas

University of Texas - MD Anderson Cancer Center, Houston, Texas

Wilford Hall Medical Center, Lackland Air Force Base, Texas

Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas

Bayshore Medical Center, Pasadena, Texas

Dixie Regional Medical Center, Saint George, Utah

University of Utah Health Sciences Center, Salt Lake City, Utah

Latter Day Saints Hospital, Salt Lake City, Utah

Vermont Cancer Center, Burlington, Vermont

Cancer Center at the University of Virginia, Charlottesville, Virginia

RMH Regional Cancer Center, Harrisonburg, Virginia

Naval Medical Center, Portsmouth, Portsmouth, Virginia

Bon Secours - St. Mary's Hospital, Richmond, Virginia

Massey Cancer Center, Richmond, Virginia

Virginia Mason Medical Center, Seattle, Washington

Deaconess Medical Center, Spokane, Washington

Yakima Valley Memorial Hospital, Yakima, Washington

Schiffler Cancer Center, Wheeling, West Virginia

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin

St. Vincent Hospital, Green Bay, Wisconsin

Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin

Southern Wisconsin Radiotherapy Center, Madison, Wisconsin

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin

Marshfield Clinic, Marshfield, Wisconsin

Community Memorial Hospital, Menomonee Falls, Wisconsin

Columbia Hospital, Milwaukee, Wisconsin

St. Luke's Medical Center, Milwaukee, Wisconsin

Medical College of Wisconsin, Milwaukee, Wisconsin

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin

All Saints Cancer Center, Racine, Wisconsin

Waukesha Memorial Hospital, Waukesha, Wisconsin

Tom Baker Cancer Center - Calgary, Calgary, Alberta

Cross Cancer Institute, Edmonton, Alberta

Saint John Regional Hospital, Saint John, New Brunswick

Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador

Nova Scotia Cancer Centre, Halifax, Nova Scotia

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario

Kingston Regional Cancer Centre, Kingston, Ontario

Cancer Care Ontario-London Regional Cancer Centre, London, Ontario

Ottawa Regional Cancer Centre, Ottawa, Ontario

Northeastern Ontario Regional Cancer Centre, Sudbury, Sudbury, Ontario

Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay, Ontario

Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario

Princess Margaret Hospital, Toronto, Ontario

CHUS-Hopital Fleurimont, Fleurimont, Quebec

Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec

McGill University, Montreal, Quebec

Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec

Allan Blair Cancer Centre, Regina, Saskatchewan

Saskatoon Cancer Centre, Saskatoon, Saskatchewan

Conditions: Head and Neck Cancer

Learn More ›

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer

NCT00011999

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy following surgery may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy plus radiation therapy in treating patients who have undergone surgery for stage III or stage IV head and neck cancer.

Gender:

ALL

Ages:

21 years and above

Trial Updated:

11/14/2015

Locations: University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama +233 locations

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama

Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama

Huntsville Hospital System, Huntsville, Alabama

MBCCOP - Gulf Coast, Mobile, Alabama

Alabama Oncology, LLC, Montgomery, Alabama

DCH Cancer Treatment Center, Tuscaloosa, Alabama

Foundation for Cancer Research and Education, Phoenix, Arizona

Mount Diablo Medical Center, Concord, California

City of Hope Comprehensive Cancer Center, Duarte, California

Saint Agnes Cancer Center, Fresno, California

California Cancer Center, Fresno, California

Sutter Health West Cancer Research Group, Greenbrae, California

Loma Linda University Medical Center, Loma Linda, California

Veterans Affairs Medical Center - Long Beach, Long Beach, California

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California

CCOP - Bay Area Tumor Institute, Oakland, California

Huntington Cancer Center, Pasadena, California

Robert and Beverly Lewis Family Cancer Care Center, Pomona, California

Radiation Oncology Center - Sacramento, Sacramento, California

Radiation Medical Group, Inc., San Diego, California

UCSF Comprehensive Cancer Center, San Francisco, California

O'Connor Hospital, San Jose, California

CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California

David Grant Medical Center, Travis Air Force Base, California

Memorial Hospital Cancer Center, Colorado Springs, Colorado

University of Colorado Cancer Center, Denver, Colorado

Saint Mary's Hospital and Medical Center, Grand Junction, Colorado

Hospital of St. Raphael, New Haven, Connecticut

CCOP - Christiana Care Health Services, Wilmington, Delaware

University of Florida Health Science Center, Gainesville, Florida

Florida Radiation Oncology Group, Jacksonville, Florida

Health First Holmes Regional Medical Center, Melbourne, Florida

CCOP - Mount Sinai Medical Center, Miami Beach, Florida

Veterans Affairs Medical Center - Miami, Miami, Florida

Sylvester Cancer Center, University of Miami, Miami, Florida

Baptist Hospital of Miami, Miami, Florida

MD Anderson Cancer Center Orlando, Orlando, Florida

Bay Medical Center, Panama City, Florida

Gulf Coast Cancer Treatment Center, Panama City, Florida

Sarasota Radiation and Medical Oncology Center, Sarasota, Florida

Tallahassee Memorial Healthcare, Tallahassee, Florida

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Emory University Hospital - Atlanta, Atlanta, Georgia

CCOP - Atlanta Regional, Atlanta, Georgia

Medical Center/John B. Amos Community Cancer Center, Columbus, Georgia

Regional Radiation Oncology Center at Rome, Rome, Georgia

MBCCOP - Hawaii, Honolulu, Hawaii

Northwest Community Hospital, Arlington Heights, Illinois

Northwestern Memorial Hospital, Chicago, Illinois

CCOP - Central Illinois, Decatur, Illinois

Ingalls Memorial Hospital, Harvey, Illinois

Loyola University Medical Center, Maywood, Illinois

Lutheran General Cancer Care Center, Park Ridge, Illinois

Methodist Medical Center of Illinois, Peoria, Illinois

St. John's Medical Center, Anderson, Indiana

Bloomington Hospital, Bloomington, Indiana

Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana

Clarian Health Partners Inc., Indianapolis, Indiana

Regional Cancer Center, Indianapolis, Indiana

Ball Memorial Hospital, Muncie, Indiana

CCOP - Northern Indiana CR Consortium, South Bend, Indiana

Wendt Regional Cancer Center of Finley Hospital, Dubuque, Iowa

Central Baptist Hospital, Lexington, Kentucky

Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky

James Graham Brown Cancer Center, Louisville, Kentucky

Louisville Radiation Oncology, Louisville, Kentucky

Merle M. Mahr Cancer Center, Madisonville, Kentucky

Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana

Tulane University School of Medicine, New Orleans, Louisiana

MBCCOP - LSU Medical Center, New Orleans, Louisiana

CCOP - Ochsner, New Orleans, Louisiana

Maine Medical Center, Portland, Maine

Anne Arundel Oncology Center, Annapolis, Maryland

Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland

Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland

Harbor Hospital Center, Baltimore, Maryland

Sinai Hospital of Baltimore, Baltimore, Maryland

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Peninsula Regional Medical Center, Salisbury, Maryland

Dana-Farber Cancer Institute, Boston, Massachusetts

Cape Cod Hospital, Hyannis, Massachusetts

Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts

CCOP - Ann Arbor Regional, Ann Arbor, Michigan

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Henry Ford Hospital, Detroit, Michigan

Hurley Medical Center, Flint, Michigan

McLaren Regional Cancer Center, Flint, Michigan

CCOP - Kalamazoo, Kalamazoo, Michigan

Marquette General Hospital, Marquette, Michigan

MidMichigan Medical Center - Midland, Midland, Michigan

CCOP - Beaumont, Royal Oak, Michigan

William Beaumont Hospital, Royal Oak, Michigan

William Beaumont Hospital - Troy, Troy, Michigan

Mayo Clinic Cancer Center, Rochester, Minnesota

CCOP - Metro-Minnesota, Saint Louis Park, Minnesota

Ellis Fischel Cancer Center - Columbia, Columbia, Missouri

CCOP - Kansas City, Kansas City, Missouri

Mallinckrodt Institute of Radiology, Saint Louis, Missouri

St. Louis University Health Sciences Center, Saint Louis, Missouri

Cancer Research for the Ozarks, Springfield, Missouri

CCOP - Cancer Research for the Ozarks, Springfield, Missouri

CCOP - Montana Cancer Consortium, Billings, Montana

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska

Methodist Hospital Cancer Center - Omaha, Omaha, Nebraska

Nebraska Health System, Omaha, Nebraska

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada

Norris Cotton Cancer Center, Lebanon, New Hampshire

Elliot Regional Cancer Center, Manchester, New Hampshire

Veterans Affairs Medical Center - East Orange, East Orange, New Jersey

John F. Kennedy Medical Center, Edison, New Jersey

Trinitas Hospital - Jersey Street Campus, Elizabeth, New Jersey

Monmouth Medical Center, Long Branch, New Jersey

South Jersey Regional Cancer Center, Millville, New Jersey

Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital, Mount Holly, New Jersey

Cancer Institute of New Jersey, New Brunswick, New Jersey

Newark Beth Israel Medical Center, Newark, New Jersey

Atlantic City Medical Center, Pomona, New Jersey

Valley Hospital, Ridgewood, New Jersey

Community Medical Center, Toms River, New Jersey

St. Francis Medical Center, Trenton, New Jersey

Associated Radiologists, P.A., Warren, New Jersey

Radiation Oncology Associates of Albuquerque, Albuquerque, New Mexico

Cancer Center of Albany Medical Center, Albany, New York

State University of New York Health Science Center at Brooklyn, Brooklyn, New York

New York Methodist Hospital, Brooklyn, New York

Roswell Park Cancer Institute, Buffalo, New York

Finger Lakes Radiation Oncology Center, Clifton Springs, New York

CCOP - North Shore University Hospital, Manhasset, New York

Herbert Irving Comprehensive Cancer Center, New York, New York

Champlain Valley Physicians Hospital Medical Center, Plattsburgh, New York

Vassar Brothers Medical Center, Poughkeepsie, New York

James P. Wilmot Cancer Center, Rochester, New York

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York

Riverhill Radiation Oncology, Yonkers, New York

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina

Northeast Medical Center, Concord, North Carolina

East Carolina University School of Medicine, Greenville, North Carolina

CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina

Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina

Trinity Cancer Care Center, Minot, North Dakota

Akron General Medical Center, Akron, Ohio

Akron City Hospital, Akron, Ohio

Christ Hospital, Cincinnati, Ohio

Barrett Cancer Center, Cincinnati, Ohio

Ireland Cancer Center, Cleveland, Ohio

University Hospitals of Cleveland, Cleveland, Ohio

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio

CCOP - Columbus, Columbus, Ohio

Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio

CCOP - Dayton, Dayton, Ohio

CCOP - Toledo Community Hospital, Toledo, Ohio

St. Anthony Hospital, Oklahoma City, Oklahoma

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

St. John Health System, Tulsa, Oklahoma

CCOP - Oklahoma, Tulsa, Oklahoma

CCOP - Columbia River Program, Portland, Oregon

Lehigh Valley Hospital, Allentown, Pennsylvania

St. Luke's Hospital Cancer Center, Bethlehem, Pennsylvania

Geisinger Medical Center, Danville, Pennsylvania

Mercy Fitzgerald Hospital, Darby, Pennsylvania

Delaware County Memorial Hospital, Drexel Hill, Pennsylvania

Pocono Cancer Center, East Stroudsburg, Pennsylvania

Milton S. Hershey Medical Center, Hershey, Pennsylvania

University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania

Veterans Affairs Medical Center - Philadelphia, Philadelphia, Pennsylvania

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Albert Einstein Cancer Center, Philadelphia, Pennsylvania

University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania

Mercy Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Western Pennsylvania Hospital, Pittsburgh, Pennsylvania

Reading Hospital and Medical Center, Reading, Pennsylvania

Mercy Hospital Cancer Center - Scranton, Scranton, Pennsylvania

Wilkes Barre General Hospital, Wilkes-Barre, Pennsylvania

York Cancer Center, York, Pennsylvania

Roger Williams Medical Center/BUSM, Providence, Rhode Island

CCOP - Greenville, Greenville, South Carolina

CCOP - Upstate Carolina, Spartanburg, South Carolina

Rapid City Regional Hospital, Rapid City, South Dakota

Jackson-Madison County General Hospital, Jackson, Tennessee

University of Tennessee Cancer Institute, Memphis, Tennessee

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee

Harrington Cancer Center, Amarillo, Texas

University of Texas Medical Branch, Galveston, Texas

University of Texas - MD Anderson Cancer Center, Houston, Texas

Wilford Hall Medical Center, Lackland Air Force Base, Texas

Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas

Dixie Regional Medical Center, Saint George, Utah

University of Utah Health Sciences Center, Salt Lake City, Utah

Latter Day Saints Hospital, Salt Lake City, Utah

Vermont Cancer Center, Burlington, Vermont

Cancer Center at the University of Virginia, Charlottesville, Virginia

RMH Regional Cancer Center, Harrisonburg, Virginia

Naval Medical Center, Portsmouth, Portsmouth, Virginia

Bon Secours - St. Mary's Hospital, Richmond, Virginia

Massey Cancer Center, Richmond, Virginia

Virginia Mason Medical Center, Seattle, Washington

Deaconess Medical Center, Spokane, Washington

Yakima Valley Memorial Hospital, Yakima, Washington

Schiffler Cancer Center, Wheeling, West Virginia

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin

St. Vincent Hospital, Green Bay, Wisconsin

Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin

Southern Wisconsin Radiotherapy Center, Madison, Wisconsin

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin

Marshfield Clinic, Marshfield, Wisconsin

Community Memorial Hospital, Menomonee Falls, Wisconsin

Columbia Hospital, Milwaukee, Wisconsin

St. Luke's Medical Center, Milwaukee, Wisconsin

Medical College of Wisconsin, Milwaukee, Wisconsin

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin

All Saints Cancer Center, Racine, Wisconsin

Waukesha Memorial Hospital, Waukesha, Wisconsin

Tom Baker Cancer Center - Calgary, Calgary, Alberta

Cross Cancer Institute, Edmonton, Alberta

Saint John Regional Hospital, Saint John, New Brunswick

Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador

Nova Scotia Cancer Centre, Halifax, Nova Scotia

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario

Kingston Regional Cancer Centre, Kingston, Ontario

Cancer Care Ontario-London Regional Cancer Centre, London, Ontario

Ottawa Regional Cancer Centre, Ottawa, Ontario

Northeastern Ontario Regional Cancer Centre, Sudbury, Sudbury, Ontario

Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay, Ontario

Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario

Princess Margaret Hospital, Toronto, Ontario

CHUS-Hopital Fleurimont, Fleurimont, Quebec

Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec

McGill University, Montreal, Quebec

Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec

Allan Blair Cancer Centre, Regina, Saskatchewan

Saskatoon Cancer Centre, Saskatoon, Saskatchewan

Conditions: Head and Neck Cancer

Learn More ›

Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers

NCT00798252

Completed

To determine safety and maximum tolerated dose of brivanib alaninate when administered in combination with capecitabine, doxorubicin, ixabepilone, docetaxel and paclitaxel chemotherapy to subjects with advanced or metastatic solid tumors

Gender:

ALL

Ages:

Between 18 years and 75 years

Trial Updated:

07/03/2015

Locations: Usc/Norris Comprehensive Cancer Center, Los Angeles, California +4 locations

Conditions: Advanced Cancer

Learn More ›

Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer

NCT00075270

Completed

The purpose of this study is to determine the efficacy and safety of an oral dual tyrosine kinase inhibitor (GW572016) in combination with paclitaxel compared to paclitaxel alone in first line advanced or metastatic breast cancer.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

04/16/2015

Locations: GSK Investigational Site, Tucson, Arizona +176 locations

GSK Investigational Site, Tucson, Arizona

GSK Investigational Site, Hot Springs, Arkansas

GSK Investigational Site, Jonesboro, Arkansas

GSK Investigational Site, Fountain Valley, California

GSK Investigational Site, La Jolla, California

GSK Investigational Site, Rancho Mirage, California

GSK Investigational Site, Vallejo, California

GSK Investigational Site, Denver, Colorado

GSK Investigational Site, Boca Raton, Florida

GSK Investigational Site, Orlando, Florida

GSK Investigational Site, Port St. Lucie, Florida

GSK Investigational Site, West Palm Beach, Florida

GSK Investigational Site, Atlanta, Georgia

GSK Investigational Site, Marietta, Georgia

GSK Investigational Site, Savannah, Georgia

GSK Investigational Site, Indianapolis, Indiana

GSK Investigational Site, Kansas City, Kansas

GSK Investigational Site, Metairie, Louisiana

GSK Investigational Site, Baltimore, Maryland

GSK Investigational Site, Glen Burnie, Maryland

GSK Investigational Site, Springfield, Massachusetts

GSK Investigational Site, Duluth, Minnesota

GSK Investigational Site, Robbinsdale, Minnesota

GSK Investigational Site, St. Louis, Missouri

GSK Investigational Site, Voorhees, New Jersey

GSK Investigational Site, Santa Fe, New Mexico

GSK Investigational Site, Nyack, New York

GSK Investigational Site, Syracuse, New York

GSK Investigational Site, Charlotte, North Carolina

GSK Investigational Site, Greenville, North Carolina

GSK Investigational Site, Fargo, North Dakota

GSK Investigational Site, Canton, Ohio

GSK Investigational Site, Portland, Oregon

GSK Investigational Site, Columbia, South Carolina

GSK Investigational Site, Knoxville, Tennessee

GSK Investigational Site, Amarillo, Texas

GSK Investigational Site, Fort Worth, Texas

GSK Investigational Site, Houston, Texas

GSK Investigational Site, San Antonio, Texas

GSK Investigational Site, Burlington, Vermont

GSK Investigational Site, Norfolk, Virginia

GSK Investigational Site, Tacoma, Washington

GSK Investigational Site, Milwaukee, Wisconsin

GSK Investigational Site, Capital Federal, Buenos Aires

GSK Investigational Site, Buenos Aires, Not set

GSK Investigational Site, Fitzroy, Victoria

GSK Investigational Site, Malvern, Victoria

GSK Investigational Site, Wodonga, Victoria

GSK Investigational Site, Nedlands, Western Australia

GSK Investigational Site, Vienna, Not set

GSK Investigational Site, Brugge, Not set

GSK Investigational Site, Brussels, Not set

GSK Investigational Site, Brussel, Not set

GSK Investigational Site, Kortrijk, Not set

GSK Investigational Site, Leuven, Not set

GSK Investigational Site, Roeselare, Not set

GSK Investigational Site, Salvador, Bahía

GSK Investigational Site, Rio de Janeiro, Not set

GSK Investigational Site, Saint John's, Newfoundland and Labrador

GSK Investigational Site, Sudbury, Ontario

GSK Investigational Site, Thunder Bay, Ontario

GSK Investigational Site, Montreal, Quebec

GSK Investigational Site, Sherbrooke, Quebec

GSK Investigational Site, Santiago, Región Metro De Santiago

GSK Investigational Site, Brno, Not set

GSK Investigational Site, Hradec Kralove, Not set

GSK Investigational Site, Olomouc, Not set

GSK Investigational Site, Aalen, Baden-Wuerttemberg

GSK Investigational Site, Stuttgart, Baden-Wuerttemberg

GSK Investigational Site, Ulm, Baden-Wuerttemberg

GSK Investigational Site, Augsburg, Bayern

GSK Investigational Site, Bayreuth, Bayern

GSK Investigational Site, Coburg, Bayern

GSK Investigational Site, Muenchen, Bayern

GSK Investigational Site, Fuerstenwalde, Brandenburg

GSK Investigational Site, Stade, Niedersachsen

GSK Investigational Site, Herne, Nordrhein-Westfalen

GSK Investigational Site, Ibbenbueren, Nordrhein-Westfalen

GSK Investigational Site, Muenster, Nordrhein-Westfalen

GSK Investigational Site, Halle, Sachsen-Anhalt

GSK Investigational Site, Kiel, Schleswig-Holstein

GSK Investigational Site, Jena, Thueringen

GSK Investigational Site, Berlin, Not set

GSK Investigational Site, Hamburg, Not set

GSK Investigational Site, Budapest, Not set

GSK Investigational Site, Nyíregyháza, Not set

GSK Investigational Site, Szombathely, Not set

GSK Investigational Site, Zalaegerszeg-Pózva, Not set

GSK Investigational Site, Benevento, Campania

GSK Investigational Site, Napoli, Campania

GSK Investigational Site, Forlì, Emilia-Romagna

GSK Investigational Site, Parma, Emilia-Romagna

GSK Investigational Site, Ravenna, Emilia-Romagna

GSK Investigational Site, Rimini, Emilia-Romagna

GSK Investigational Site, Roma, Lazio

GSK Investigational Site, Pietra Ligure (SV), Liguria

GSK Investigational Site, Bergamo, Lombardia

GSK Investigational Site, Pavia, Lombardia

GSK Investigational Site, Candiolo (TO), Piemonte

GSK Investigational Site, Torino, Piemonte

GSK Investigational Site, Sassari, Sardegna

GSK Investigational Site, Prato (PO), Toscana

GSK Investigational Site, Perugia, Umbria

GSK Investigational Site, Gyeonggi-do, Not set

GSK Investigational Site, Seoul, Not set

GSK Investigational Site, Daugavpils, Not set

GSK Investigational Site, Liepaja, Not set

GSK Investigational Site, Riga, Not set

GSK Investigational Site, Acapulco, Guerrero

GSK Investigational Site, Guadalajara, Jalisco

GSK Investigational Site, Colima, Not set

GSK Investigational Site, Durango, Not set

GSK Investigational Site, Amersfoort, Not set

GSK Investigational Site, Leiden, Not set

GSK Investigational Site, Nieuwegein, Not set

GSK Investigational Site, Utrecht, Not set

GSK Investigational Site, Auckland, Not set

GSK Investigational Site, Christchurch, Not set

GSK Investigational Site, Lahore, Not set

GSK Investigational Site, Callao, Not set

GSK Investigational Site, Lima, Not set

GSK Investigational Site, Krakow, Not set

GSK Investigational Site, Olsztyn, Not set

GSK Investigational Site, Poznan, Not set

GSK Investigational Site, Warszawa, Not set

GSK Investigational Site, Wroclaw, Not set

GSK Investigational Site, Moscow Region, Not set

GSK Investigational Site, Moscow, Not set

GSK Investigational Site, St. Petersburg, Not set

GSK Investigational Site, Banska Bystrica, Not set

GSK Investigational Site, Bratislava, Not set

GSK Investigational Site, Kosice, Not set

GSK Investigational Site, Poprad, Not set

GSK Investigational Site, Parktown, Gauteng

GSK Investigational Site, Capital Park, Not set

GSK Investigational Site, Overport, Not set

GSK Investigational Site, Parow, Not set

GSK Investigational Site, Port Elizabeth, Not set

GSK Investigational Site, Alcorcón/Madrid, Not set

GSK Investigational Site, Baracaldo/Vizcaya, Not set

GSK Investigational Site, Caceres, Not set

GSK Investigational Site, Cuidad Real, Not set

GSK Investigational Site, Jaen, Not set

GSK Investigational Site, La Laguna (Santa Cruz de Tenerife), Not set

GSK Investigational Site, Las Palmas De Gran Canaria, Not set

GSK Investigational Site, Madrid, Not set

GSK Investigational Site, Móstoles/Madrid, Not set

GSK Investigational Site, Palma de Mallorca, Not set

GSK Investigational Site, Pontevedra, Not set

GSK Investigational Site, San Sebastián, Not set

GSK Investigational Site, Santa Cruz de Tenerife, Not set

GSK Investigational Site, Zaragoza, Not set

GSK Investigational Site, Istanbul, Not set

Conditions: Neoplasms, Breast

Learn More ›

Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer

NCT00254891

Terminated

To assess the efficacy and safety of PF-3512676 administered in combination with paclitaxel/carboplatin chemotherapy as first-line treatment in patients with locally advanced or metastatic Non-Small-Cell Lung Cancer (NSCLC) and to compare it to the efficacy and safety of paclitaxel

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/10/2015

Locations: Pfizer Investigational Site, Little Rock, Alaska +190 locations

Pfizer Investigational Site, Little Rock, Alaska

Pfizer Investigational Site, Hot Springs, Arkansas

Pfizer Investigational Site, Chula Vista, California

Pfizer Investigational Site, La Mesa, California

Pfizer Investigational Site, Oceanside, California

Pfizer Investigational Site, Palm Springs, California

Pfizer Investigational Site, San Diego, California

Pfizer Investigational Site, San Francisco, California

Pfizer Investigational Site, Atlanta, Georgia

Pfizer Investigational Site, Decatur, Georgia

Pfizer Investigational Site, Fayetteville, Georgia

Pfizer Investigational Site, Macon, Georgia

Pfizer Investigational Site, Marietta, Georgia

Pfizer Investigational Site, Tucker, Georgia

Pfizer Investigational Site, Rockford, Illinois

Pfizer Investigational Site, Jefferson, Indiana

Pfizer Investigational Site, New Albany, Indiana

Pfizer Investigational Site, Cedar Rapids, Iowa

Pfizer Investigational Site, Dubuque, Iowa

Pfizer Investigational Site, Lexington, Kentucky

Pfizer Investigational Site, Louisville, Kentucky

Pfizer Investigational Site, Shelbyville, Kentucky

Pfizer Investigational Site, Covington, Louisiana

Pfizer Investigational Site, Gretna, Louisiana

Pfizer Investigational Site, Lafayette, Louisiana

Pfizer Investigational Site, Marrero, Louisiana

Pfizer Investigational Site, Metairie, Louisiana

Pfizer Investigational Site, New Orleans, Louisiana

Pfizer Investigational Site, Biddeford, Maine

Pfizer Investigational Site, Brunswick, Maine

Pfizer Investigational Site, Scarborough, Maine

Pfizer Investigational Site, Worcester, Massachusetts

Pfizer Investigational Site, Allegan, Michigan

Pfizer Investigational Site, Ann Arbor, Michigan

Pfizer Investigational Site, Kalamazoo, Michigan

Pfizer Investigational Site, St. Joseph, Michigan

Pfizer Investigational Site, Columbus, Mississippi

Pfizer Investigational Site, Corinth, Mississippi

Pfizer Investigational Site, Tupelo, Mississippi

Pfizer Investigational Site, Omaha, Nebraska

Pfizer Investigational Site, Papillion, Nebraska

Pfizer Investigational Site, Las Vegas, Nevada

Pfizer Investigational Site, Albuquerque, New Mexico

Pfizer Investigational Site, Ruidoso, New Mexico

Pfizer Investigational Site, Buffalo, New York

Pfizer Investigational Site, Great Neck, New York

Pfizer Investigational Site, Asheville, North Carolina

Pfizer Investigational Site, Brevard, North Carolina

Pfizer Investigational Site, Lexington, North Carolina

Pfizer Investigational Site, Winston-Salem, North Carolina

Pfizer Investigational Site, Canton, Ohio

Pfizer Investigational Site, Dover, Ohio

Pfizer Investigational Site, Oklahoma City, Oklahoma

Pfizer Investigational Site, Portland, Oregon

Pfizer Investigational Site, Langhorne, Pennsylvania

Pfizer Investigational Site, Chattanooga, Tennessee

Pfizer Investigational Site, Memphis, Tennessee

Pfizer Investigational Site, Arlington, Texas

Pfizer Investigational Site, Dallas, Texas

Pfizer Investigational Site, Richardson, Texas

Pfizer Investigational Site, Trophy Club, Texas

Pfizer Investigational Site, Bountiful, Utah

Pfizer Investigational Site, Layton, Utah

Pfizer Investigational Site, Murray, Utah

Pfizer Investigational Site, Provo, Utah

Pfizer Investigational Site, Salt Lake City, Utah

Pfizer Investigational Site, WVC, Utah

Pfizer Investigational Site, Burlington, Vermont

Pfizer Investigational Site, Everett, Washington

Pfizer Investigational Site, Kennewick, Washington

Pfizer Investigational Site, Richland, Washington

Pfizer Investigational Site, Madison, Wisconsin

Pfizer Investigational Site, Albury, New South Wales

Pfizer Investigational Site, Camperdown, New South Wales

Pfizer Investigational Site, Randwick, New South Wales

Pfizer Investigational Site, Pimlico, Queensland

Pfizer Investigational Site, Townsville, Queensland

Pfizer Investigational Site, Woolloongabba, Queensland

Pfizer Investigational Site, Bedford Park, South Australia

Pfizer Investigational Site, Toorak Gardens, South Australia

Pfizer Investigational Site, East Melbourne, Victoria

Pfizer Investigational Site, East Ringwood, Victoria

Pfizer Investigational Site, Wodonga, Victoria

Pfizer Investigational Site, Nedlands, Western Australia

Pfizer Investigational Site, Gent, Not set

Pfizer Investigational Site, Liège, Not set

Pfizer Investigational Site, Moncton, New Brunswick

Pfizer Investigational Site, Montreal, Quebec

Pfizer Investigational Site, Rimouski, Quebec

Pfizer Investigational Site, Saskatoon, Saskatchewan

Pfizer Investigational Site, Dalian, Xigang District, Liaoning

Pfizer Investigational Site, Beijing, Not set

Pfizer Investigational Site, Shanghai, Not set

Pfizer Investigational Site, Nicosia, Not set

Pfizer Investigational Site, Nova Ves Pod Plesi, Not set

Pfizer Investigational Site, Ostrava-Poruba, Not set

Pfizer Investigational Site, Usti nad Labem, Not set

Pfizer Investigational Site, Angers cedex, Not set

Pfizer Investigational Site, Caen cedex, Not set

Pfizer Investigational Site, Dijon, Not set

Pfizer Investigational Site, Limoges, Not set

Pfizer Investigational Site, Nantes Cedex 2, Not set

Pfizer Investigational Site, Paris Cedex 13, Not set

Pfizer Investigational Site, St Herblain Cedex, Not set

Pfizer Investigational Site, Strasbourg, Not set

Pfizer Investigational Site, Toulouse cedex 9, Not set

Pfizer Investigational Site, Vandoeuvre Les Nancy, Not set

Pfizer Investigational Site, Berlin, Not set

Pfizer Investigational Site, Bielefeld, Not set

Pfizer Investigational Site, Bonn, Not set

Pfizer Investigational Site, Essen, Not set

Pfizer Investigational Site, Frankfurt, Not set

Pfizer Investigational Site, Karlsruhe, Not set

Pfizer Investigational Site, Muenchen, Not set

Pfizer Investigational Site, Athens, Attica

Pfizer Investigational Site, Heraklion, Crete

Pfizer Investigational Site, Thessaloniki, Macedonia

Pfizer Investigational Site, Athens, Not set

Pfizer Investigational Site, Rio, Patras, Not set

Pfizer Investigational Site, Pokfulam, Not set

Pfizer Investigational Site, Budapest, Not set

Pfizer Investigational Site, Debrecen, Not set

Pfizer Investigational Site, Bangalore, Karnataka

Pfizer Investigational Site, Kochi, Kerala

Pfizer Investigational Site, Pune, Maharashtra

Pfizer Investigational Site, Chandigarh, Punjab

Pfizer Investigational Site, Jaipur, Rajasthan

Pfizer Investigational Site, Zerifin, Not set

Pfizer Investigational Site, Lido di Camaiore (LU), Not set

Pfizer Investigational Site, Milano, Not set

Pfizer Investigational Site, Napoli, Not set

Pfizer Investigational Site, Pavia, Not set

Pfizer Investigational Site, Seoul, Not set

Pfizer Investigational Site, Mexico, DF

Pfizer Investigational Site, Puebla, Not set

Pfizer Investigational Site, Tiel, GLD

Pfizer Investigational Site, Groningen, GR

Pfizer Investigational Site, Amstelveen, Not set

Pfizer Investigational Site, Den Haag, Not set

Pfizer Investigational Site, Otwock, Not set

Pfizer Investigational Site, Wodzislaw Sl., Not set

Pfizer Investigational Site, Faro, Not set

Pfizer Investigational Site, Porto, Not set

Pfizer Investigational Site, Vila Nova de Gaia, Not set

Pfizer Investigational Site, Parktown, Gauteng

Pfizer Investigational Site, Cape Town, Not set

Pfizer Investigational Site, Johannesburg, Not set

Pfizer Investigational Site, Badalona, Barcelona

Pfizer Investigational Site, Alcorcon, Madrid

Pfizer Investigational Site, Pamplona, Navarra

Pfizer Investigational Site, Madrid, Not set

Pfizer Investigational Site, Santa Cruz de Tenerife, Not set

Pfizer Investigational Site, Valencia, Not set

Pfizer Investigational Site, Stockholm, Not set

Pfizer Investigational Site, Uppsala, Not set

Pfizer Investigational Site, Lausanne, Not set

Pfizer Investigational Site, Taipei, Not set

Pfizer Investigational Site, Truro, Cornwall

Pfizer Investigational Site, Exeter, Devon

Pfizer Investigational Site, London, Not set

Pfizer Investigational Site, Portsmouth, Not set

Pfizer Investigational Site, Sheffield, Not set

Pfizer Investigational Site, Surrey GU2 5XX, Not set

Pfizer Investigational Site, Swansea, Not set

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

Paclitaxel Eluting Balloon for SFA In-stent Restenosis

NCT01616888

Unknown

The purpose of the study is to evaluate the safety and efficacy on the use of drug eluting balloon (DEB) with paclitaxel to treat in-stent restenosis in femoropopliteal arteries.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

12/05/2014

Locations: University Health Network, Toronto, Ontario

Conditions: In-stent Arterial Restenosis

Learn More ›

A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer

NCT02004093

Completed

This study will evaluate the efficacy and safety of pertuzumab in combination with carboplatin-based standard chemotherapy in patients with platinum-sensitive recurrent ovarian cancer. The anticipated time on study treatment is 3-12 months.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/25/2014

Locations: Not set, Bruxelles, Not set +33 locations

Conditions: Ovarian Cancer

Learn More ›